Company page

Summit Therapeutics Inc.

Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.